2009

December 07, 2009 Nutra Pharma Completes FDA Submission for Nyloxin OTC and Nyloxin Rx - Over-the-Counter and Prescription Treatments for Chronic Pain

December 03, 2009 Nutra Pharma Announces Upcoming Webinar to Discuss the Company's Over-the-Counter (OTC) and Prescription Treatments for Chronic Pain

November 19, 2009 Nutra Pharma Introduces Chronic Pain Reliever, Nyloxin OTC, for International Distribution

October 14, 2009 Nutra Pharma Announces Online Availability of Cobroxin for the Treatment of Moderate to Severe Chronic Pain

October 07, 2009 Nutra Pharma Announces Nyloxin Rx, a Prescription Analgesic for the Treatment of Severe (Stage 3) Chronic Pain

October 02, 2009 Nutra Pharma Announces Manufacturing Release of Cobroxin, a Treatment for Chronic Pain

September 21, 2009 Nutra Pharma Announces Plans to Begin Drug Registration Process in Canada and Europe for its Over-the-Counter Pain Reliever

August 31, 2009 Nutra Pharma's Recently Launched Pain Reliever, Cobroxin, Wins "Best New Product" Award at Retailing Conference

August 26, 2009 Nutra Pharma Announces Licensing Agreement with XenaCare Holdings to Market and Distribute Cobroxin, a Treatment for Chronic Pain

August 24, 2009 Nutra Pharma Completes FDA Submission for Cobroxin - a Drug for the Treatment of Stage 2 (Moderate to Severe) Chronic Pain

August 20, 2009 Nutra Pharma Announces Launch of Cobroxin, an Over-The-Counter (OTC) Treatment for Stage 2 (Moderate to Severe) Chronic Pain

August 13, 2009 Nutra Pharma Subsidiary, ReceptoPharm, Files Patent Application for the Oral Delivery of Cobra Venom for the Treatment of Pain

June 08, 2009 Nutra Pharma Announces Study Showing RPI-78 More Effective than Morphine in the Treatment of Moderate to Severe Pain

March 26, 2009 Nutra Pharma Subsidiary, ReceptoPharm, Introduces Cost Effective Contract Research Services for Early Stage Life Science Firms

March 09, 2009 Nutra Pharma Subsidiary, ReceptoPharm, Announces Achievement of ISO Class 5 Cleanroom Certification

February 17, 2009 Nutra Pharma Announces Publication of Positive Results of ReceptoPharm Arthritis Study

February 09, 2009 Nutra Pharma Subsidiary, ReceptoPharm, Files Patent Application for Novel Treatment of Arthritis Using RPI-78

2008

December 08, 2008 Nutra Pharma Receives Clinical Drug Supply Contract

November 17, 2008 Nutra Pharma Announces Provision of RPI-78M under Compassionate Release to Adrenomyeloneuropathy (AMN) Patients

August 14, 2008 Nutra Pharma Announces Initial Positive Safety Data from Clinical Study in Adrenomyeloneuropathy (AMN)

August 06, 2008 Nutra Pharma Announces Collaborative Agreement with Centers for Disease Control and Prevention (CDC)

July 29, 2008 Nutra Pharma Announces Completion of Clinical Study in Adrenomyeloneuropathy (AMN)

May 19, 2008 Nutra Pharma Subsidiary, ReceptoPharm, Receives Approval to Begin Clinical Trials for the Treatment of Feline Leukemia Virus (FeLV)

April 14, 2008 Nutra Pharma Acquires Remaining Interest in Biopharmaceutical Drug Discovery Company - ReceptoPharm, Inc.

2007

December 17, 2007 Nutra Pharma Announces Successful Completion of 6-Month Patient Crossover in AMN Clinical Trial

November 28, 2007 Nutra Pharma Posts ReceptoPharm Peer-Reviewed Article to Its Website

August 08, 2007 Nutra Pharma Announces Positive Results of ReceptoPharm Pain Study

July 10, 2007 Nutra Pharma Announces Successful Enrollment in ReceptoPharm Adrenomyeloneuropathy (AMN) Study

April 17, 2007 Nutra Pharma Announces Successful Completion of Joint Venture Meetings in China

April 11, 2007 Nutra Pharma Announces ReceptoPharm Patent for a Method of Treating Multiple Sclerosis

March 22, 2007 Nutra Pharma Announces Publication of Research on Treatment for Multiple Sclerosis

March 07, 2007 Nutra Pharma Announces ReceptoPharm's Joint Venture with Chinese Biotechnology Company

February 07, 2007 ReceptoPharm Expands Antiviral Clinical Research to South America

January 29, 2007 ReceptoPharm Begins Phase IIb Human Clinical Trial for the Treatment of Adrenomyeloneuropathy

January 16, 2007 Nutra Pharma Sponsors Educational Website for Adrenomyeloneuropathy (AMN)

January 11, 2007 Nutra Pharma Announces Breakthrough Research in the Treatment of Viral Infections

2006

November 28, 2006 Nutra Pharma Announces ReceptoPharm to Present at the International Conference on Neurotoxins

October 05, 2006 Nutra Pharma Announces Final Approval to Begin Phase IIb Human Clinical Trial for the Treatment of Adrenomyeloneuropathy

September 21, 2006 Nutra Pharma Announces ReceptoPharm to Be a Featured Speaker at the 11th Annual Immunobiology Symposium

August 29, 2006 Nutra Pharma Announces Former GlaxoSmithKline Global Clinical Development Director Joins ReceptoPharm Scientific Advisory Board

August 21, 2006 Nutra Pharma Announces Publication of Positive Results of ReceptoPharm Pain Study

June 19, 2006 ReceptoPharm Signs Letter of Intent to Be Acquired by Nutra Pharma Corporation

May 09, 2006 Nutra Pharma Announces Approval to Start Late Phase II Human Trials in England

February 09, 2006 Nutra Pharma Reports Preclinical Results of RPI-78M in Multiple Sclerosis to Be Presented at Scientific Meeting

2005

December 20, 2005 Nutra Pharma Reports Final Results for ReceptoPharm's RPI-78M in Multiple Sclerosis Animal Model

December 19, 2005 Nutra Pharma Reports Discovery of New Gene Involved in Multiple Sclerosis

October 12, 2005 Nutra Pharma Announces ReceptoPharm Facilities Have Been GMP-Certified for Drug Production

September 16, 2005 Nutra Pharma Announces RPI-MN Shows Positive Effects against Drug-Resistant Strains of HIV

February 08, 2005 Nutra Pharma Reports that ReceptoPharm will be Presenting at The Adrenomyeloneuropathy (AMN) Forum in London

2004

November 15, 2004 Nutra Pharma Reports Preliminary Results of ReceptoPharm's Multiple Sclerosis Drug in Microarray Studies

October 04, 2004 Nutra Pharma Reports Positive Results For ReceptoPharm's RPI-78M in Multiple Sclerosis Animal Model

September 01, 2004 Nutra Pharma Reports ReceptoPharm Assays Prove That Experimental HIV Drug May Be Widely Available after Approval

August 02, 2004 Nutra Pharma Engages Research Group to Study RPI-78M in Multiple Sclerosis Assays

May 18, 2004 Nutra Pharma Reports ReceptoPharm's Completion of a Critical First Step in Their Lead Drug's Production

May 05, 2004 Nutra Pharma Reports Successful Completion of ReceptoPharm's HIV In-Vitro Studies at Two Leading Universities

2003

October 06, 2003 Nutra Pharma Corporation Receives Licenses to Intellectual Property in Settlement with Bio Therapeutics Inc.